10-K Decoder · All companies

Heron Therapeutics, Inc.

HRTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$155M$144M+7.4%
Operating income−$2.54M−$11.5M+78.0%
Net income−$20.2M−$13.6M−48.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$35.2M$38.2M−7.9%
Operating income−$1.70M−$4.10M+58.5%
Net income−$5.00M−$17.5M+71.4%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Heron Therapeutics's revenue in FY2025?
$155M in FY2025 (Fiscal year ended Dec 31, 2025), +7.4% vs $144M a year earlier, per its 10-K filed Feb 2026.
Was Heron Therapeutics profitable in FY2025?
No: net income was −$20.2M and operating income −$2.54M in FY2025.
What was Heron Therapeutics's revenue in Q3 2026?
$35.2M (−7.9% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.